药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Oxamniquine
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Nilotinib.
Oxamniquine
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Nilotinib.
Oxamniquine
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Nilotinib.
Oxamniquine
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Nilotinib.
Oxamniquine
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Nilotinib.
Oxamniquine
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Nilotinib.
Oxamniquine
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Nilotinib.
Oxamniquine
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Nilotinib.
Oxamniquine
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Nilotinib.
Oxamniquine
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Nilotinib.
Oxamniquine
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Nilotinib.
Oxamniquine
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Nilotinib.
Oxamniquine
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Nilotinib.
Oxamniquine
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Nilotinib.
Oxamniquine
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Nilotinib.
Oxamniquine
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Nilotinib.
Oxamniquine
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Nilotinib.
Oxamniquine
Niguldipine
The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Nilotinib.
Oxamniquine
Lacidipine
The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Nilotinib.
Oxamniquine
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Nilotinib.